735 results on '"Diatchenko, Luda"'
Search Results
202. Letting the Gene out of the Bottle
203. Development New Pain Targets in the Genomic Era
204. Carbonic anhydrase-8 gene therapy inhibits the ITPR1-cytosolic free calcium pathway producing analgesia and anti-hyperalgesia
205. Translational research in the genomic era: OPPERA study
206. Association between INADL genetic variant and a subgroup with high risk for TMD in the OPPERA study
207. Facial pain with localized and widespread manifestations: Separate pathways of vulnerability
208. A Genome-wide Drosophila Screen for Heat Nociception Identifies alpha 2 delta 3 as an Evolutionarily Conserved Pain Gene
209. Multisystem Dysregulation in Painful Temporomandibular Disorders
210. Complex Multilocus Effects of Catechol-O-Methyltransferase Haplotypes Predict Pain and Pain Interference 6 Weeks After Motor Vehicle Collision
211. Pain modality- and sex-specific effects of COMT genetic functional variants
212. Polymorphisms in the glucocorticoid receptor co-chaperone FKBP5 predict persistent musculoskeletal pain after traumatic stress exposure
213. Correlation of Transcription of MALAT-1, a Novel Noncoding RNA, with Deregulated Expression of Tumor Suppressor p53 in Small DNA Tumor Virus Models
214. Agonist-dependence of functional properties for common nonsynonymous variants of human transient receptor potential vanilloid 1.
215. Human Genetic Variability Contributes to Postoperative Morphine Consumption.
216. Differences in the Antinociceptive Effects and Binding Properties of Propranolol and Bupranolol Enantiomers.
217. Quantitative H2S-mediated protein sulfhydration reveals metabolic reprogramming during the Integrated Stress Response.
218. Genome-wide association meta-analyses to identify common genetic variants associated with hallux valgus in Caucasian and African Americans.
219. Construction of a Global Pain Systems Network Highlights Phospholipid Signaling as a Regulator of Heat Nociception
220. Relationship Between Temporomandibular Disorders, Widespread Palpation Tenderness, and Multiple Pain Conditions: A Case-Control Study
221. Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity
222. Catechol-O-Methyltransferase Genotype Predicts Pain Severity in Hospitalized Burn Patients
223. Excess Risk of Temporomandibular Disorder Associated With Cigarette Smoking in Young Adults
224. Tissue-Specific Regulation Of Microrna-374 Family And Its mRNA Targets Associated With Pain In Humans And Mice
225. Cytokine biomarkers and chronic pain: Association of genes, transcription, and circulating proteins with temporomandibular disorders and widespread palpation tenderness
226. Relax, you won't feel the pain
227. Potential Autonomic Risk Factors for Chronic TMD: Descriptive Data and Empirically Identified Domains from the OPPERA Case-Control Study
228. Study Methods, Recruitment, Sociodemographic Findings, and Demographic Representativeness in the OPPERA Study
229. Potential Genetic Risk Factors for Chronic TMD: Genetic Associations from the OPPERA Case Control Study
230. Structural Basis for μ-Opioid Receptor Binding and Activation
231. Elucidation of mu-opioid gene structure: How genetics can help predict therapeutic response to opioids
232. Summary of Findings from the OPPERA Baseline Case-Control Study: Implications and Future Directions
233. Structural Mechanism of S-Adenosyl Methionine Binding to Catechol O-Methyltransferase
234. Catechol O-Methyltransferase Haplotype Predicts Immediate Musculoskeletal Neck Pain and Psychological Symptoms After Motor Vehicle Collision
235. A Genome-wide Drosophila Screen for Heat Nociception Identifies α2δ3 as an Evolutionarily Conserved Pain Gene
236. Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study
237. Pain perception is altered by a nucleotide polymorphism in SCN9A
238. A Novel Alternatively Spliced Isoform of the Mu-Opioid Receptor: Functional Antagonism
239. Low Enzymatic Activity Haplotypes of the Human Catechol-O-Methyltransferase Gene: Enrichment for Marker SNPs
240. Characterization of NF-Kb-Mediated Inhibition of Catechol-O-Methyltransferase
241. Responses to Drs. Kim and Dionne regarding comments on Diatchenko, et al. Catechol- O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006;125:216–24
242. Expansion of the human μ-opioid receptor gene architecture: novel functional variants
243. Haplotype associations with quantitative traits in the presence of complex multilocus and heterogeneous effects
244. Orthodontic Treatment, Genetic Factors, and Risk of Temporomandibular Disorder
245. Homogeneous reporter system enables quantitative functional assessment of multiple transcription factors
246. Genetic architecture of human pain perception
247. Catechol- O -methyltransferase inhibition increases pain sensitivity through activation of both β2- and β3-adrenergic receptors
248. β2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-κB-independent mechanisms
249. Epistasis between polymorphisms in COMT, ESR1, and GCH1 influences COMT enzyme activity and pain.
250. Three major haplotypes of the β2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.